NASDAQ: BIOL - BIOLASE, Inc.

Rentabilität für sechs Monate: -91.37%
Sektor: Healthcare

Aktionsplan BIOLASE, Inc.

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.

Weitere Details
The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, therapy pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

Цена ао 0.1603
Выручка 0.0378
EBITDA -0.0146
Число акций ао 0.001278 млрд
P/S 0.3879
P/BV 38.89
EV/EBITDA -1.53
ISIN US0909114052
Сайт https://www.biolase.com
Див.доход ао 0.7874
Дивиденд ао 229.7
Валюта usd
IPO date 1992-11-13
Sector Health Care
Industry Health Care Equipment & Supplies
Валюта отчета usd
Preisänderung pro Tag: -22.58% (0.0155)
Preisänderung pro Woche: -22.58% (0.0155)
Preisänderung pro Monat: -76% (0.05)
Preisänderung über 3 Monate: -84.42% (0.077)
Preisänderung über sechs Monate: -91.37% (0.139)
Preisänderung pro Jahr: -99.31% (1.74)
Preisänderung über 3 Jahre: -98.01% (0.6029)
Preisänderung über 5 Jahre: -98.83% (1.03)
Preisänderung seit Jahresbeginn: -99.02% (1.22)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 0.0302 10
P/BV -6 0
P/E 0 0
EV/EBITDA -0.8472 0
Gesamt: 5

Effizienz

Name Bedeutung Grad
ROA, % -58.78 0
ROE, % 8353.04 10
Gesamt: 3.33

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0.6667 6.67
Gesamt: 1.08

Pflicht

Name Bedeutung Grad
Debt/EBITDA -0.9865 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 30.06 5
Rentabilität Ebitda, % 3.69 1
Rentabilität EPS, % -16.09 0
Gesamt: 2.4
Weitere Details

Institutionen Volumen Aktie, %
Anson Funds Management LP 185127 0.57
Blackrock Inc. 25018 0.08
Kellett Schaffner Wealth Advisors LLC 19060 0.06
Citadel Advisors Llc 13818 0.04
Zhang Financial LLC 13770 0.04
Virtu Financial LLC 12289 0.04
Vanguard Group Inc 10911 0.03
Two Sigma Investments, LP 10726 0.03
UBS Group AG 5615 0.02
Tower Research Capital LLC (TRC) 2447 0.01



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. John R. Beaver President, CEO & Director 377.53k 1961 (63 Jahr)
Ms. Jennifer Bright Chief Financial Officer 355.98k 1972 (52 Jahr)
Mr. Steven Sandor Chief Operating Officer 336.39k 1981 (43 Jahr)
Mr. Michael C. Carroll Corporate Secretary N/A 1972 (52 Jahr)

Adresse: United States, Foothill Ranch. CA -, 27042 Towne Centre Drive - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.biolase.com